{"schema_version":"secwatch.filing_event.v1","accession":"0001549084-22-000029","form_type":"8-K","ticker":"CHRN","cik":"0001549084","company_name":"EKSO BIONICS HOLDINGS, INC.","filed_at":"2022-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.151388+00:00","generated_at":"2026-06-25T02:44:28.358830+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"confidence":"high","headline":"EKSO shareholders approve equity plan share increase and all proposals at annual meeting","bullets":["Elected six directors; average votes for ~4.2M per nominee, with 2.57M broker non-votes each.","Approved equity plan amendment raising authorized shares from 1,974,286 to 2,524,286; 3.9M for, 621k against.","Non-binding say-on-pay approved with 4.24M for, 255k against, 43.6k abstain.","Ratified WithumSmith+Brown as auditor for FY2022 with 6.99M for, 55.7k against.","Approximately 7.1M shares voted of 12.8M outstanding, constituting a quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001549084-22-000029","json":"https://secwatch.observer/filing/0001549084-22-000029.json","markdown":"https://secwatch.observer/filing/0001549084-22-000029.md","text":"https://secwatch.observer/filing/0001549084-22-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549084/000154908422000029/0001549084-22-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549084/000154908422000029/ekso-20220609.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:44:28.358830+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}